Alison Cecily Finger's most recent trade in Adma Biologics Inc was a trade of 17,730 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adma Biologics Inc | Alison Cecily Finger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 17,730 | 17,730 | - | - | Stock Option (Right to Buy) | |
| Adma Biologics Inc | Alison Cecily Finger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 10,690 | 45,619 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Alison Cecily Finger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 16,279 | 16,279 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Alison Cecily Finger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 10,889 | 34,929 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Finger Alison Cecily | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 37,541 | 37,541 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Alison Finger Cecily | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 24,040 | 24,040 (0%) | 0% | 0 | Common Stock | |
| Decibel Therapeutics Inc | Alison Cecily Finger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |